FDA clears AI software for flagging signs of vascular disease - Cardiovascular Business

The FDA has approved new AI software that can detect signs of vascular disease in patients, potentially catching serious health problems earlier. This brings AI medical tools closer to helping doctors improve patient outcomes in real clinical settings.